Table 2.
Comparison of clinical characteristics before and after sodium-glucose cotransporter 2 inhibitors treatment for three months.
| Characteristics | Baseline (n = 93) |
Follow-up (n = 93) |
p value |
|---|---|---|---|
| Initial proteinuria, g/24 h median, IQR |
1.32 (1.00 to 2.24) | 1.07 (0.65–1.68) | <0.001 |
| Albumin, g/L | 40.7 ± 4.0 | 41.4 ± 4.1 | 0.001 |
| eGFR, ml/min/1.73m2 mean ± SD |
58 ± 22 | 56 ± 21 | 0.008 |
| SBP, mmHg, mean ± SD | 124 ± 12 | 124 ± 13 | 0.947 |
| DBP, mmHg, mean ± SD | 80 ± 9 | 79 ± 10 | 0.326 |
| Urine sodium excretion median, IQR |
162 (126 to 209) | 163 (126 to 195) | 0.119 |
| Hematuria, RBC/HPF | 12.3 (3.5 to 38.2) | 8.9 (2.6 to 28.8) | 0.001 |
SD, standard deviation; IQR, interquartile range; eGFR, estimated glomerular filtration rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; RBC, red blood cell; HPF, high-power field.